Maternal health outcomes in the context of fragility: a retrospective study from Lebanon

Dimassi, Hani; Alameddine, Mohamad; Sabra, Nadine; El Arnaout, Nour; Harb, Ranime; Hamadeh, Randa; El Kak, Faysal; Shanaa, Abed; Mossi, Marta Orozco; Saleh, Shadi; AlArab, Natally

doi:10.1186/s13031-023-00558-1

Conflict and Health

Table 3 Supplements use, laboratory tests, and ultrasound imaging for pregnant women attending PHC centers by ANC visits, delivery outcome and delivery onset of latest/most recent pregnancy

From: Maternal health outcomes in the context of fragility: a retrospective study from Lebanon

	Number of ANC visits			Delivery outcome					Delivery onset
	ANC < 4			C-section		Abortion			Preterm
	N	%	p-value	N	%	N	%	p-value	N	%	p-value
Supplements
Folic Acid (yes)	1129	30.2%	.996	1540^a	41.1%	297^a	7.9%	< .001	426	13.2%	.054
Folic Acid (no)	66	30.1%		48^b	21.9%	13^a	5.9%		30	18.5%
Iron (yes)	859	24.7%	< .001	1505^a	43.3%	97^a	2.8%	< .001	417	13.0%	.001
Iron (no)	336	68.6%		83^b	16.9%	21^b	43.5%		39	21.5%
Lab Tests
CBC (yes)	1065	29.6%	.001	1433^a	39.8%	273^a	7.6%	.028	403	13.1%	.052
CBC (no)	142	37.9%		157^a	41.9%	41^b	10.9%		53	17.0%
FBS (yes)	965	28.1%	< .001	1411^a	41.1%	245^a	7.1%	< .001	391	13.2%	.301
FBS (no)	242	44.4%		179^b	32.8%	69^b	12.7%		65	15.0%
OGTT (yes)	158	15.2%	< .001	350^a	33.6%	31^a	3.0%	< .001	87	9.6%	< .001
OGTT (no)	338	46.9%		293^b	40.6%	101^b	14.0%		92	15.8%
Ferritin (yes)	69	36.9%	.046	25^a	13.4%	7^a	3.7%	< .001	1	0.8%	< .001
Ferritin (no)	1138	30.0%		1565^b	41.3%	307^b	8.1%		455	14.0%
Urinalysis (yes)	888	28.9%	< .001	1197^a	39.0%	226^a	7.4%	.001	334	12.8%	.047
Urinalysis (no)	319	35.3%		393^b	43.5%	88^b	9.7%		122	15.6%
Hepatitis B (yes)	251	33.2%	< .001	122^a	16.1%	27^a	3.6%	< .001	99	17.2%	.077
Hepatitis B (no)	104	71.2%		16^a	11.0%	25^b	17.1%		2	5.7%
Rubella (yes)	299	36.3%	< .001	123^a	14.9%	32^a	3.9%	< .001	98	16.5%	.626
Rubella (no)	56	74.7%		15^a	20.0%	20^b	26.7%		3	21.4%
Syphilis (yes)	253	33.0%	< .001	134^a	17.5%	28^a	3.7%	< .001	102	17.3%	.066
Syphilis (no)	107	70.9%		18^a	11.9%	26^b	17.2%		2	5.6%
HIV (yes)	299	36.1%	< .001	125^a	15.1%	32^a	3.9%	< .001	97	16.2%	.413
HIV (no)	58	77.3%		17^b	22.7%	21^b	28.0%		3	25.0%
Toxoplasmosis (yes)	292	36.6%	< .001	125^a	15.7%	32^a	4.0%	< .001	103	18.2%	.001
Toxoplasmosis (no)	61	70.9%		16^a	18.6%	19^b	22.1%		2	6.5%
Ultrasounds done			< .001					< .001			< .001
None	311^a	52.8%		253^a	43.0%	105^a	17.8%		56^a	12.0%
1	496^a	30.5%		674^a	41.5%	187^b	11.5%		225^b	16.9%
≥ 2	400^c	22.7%		663^b	37.6%	22^c	1.2%		175^a	11.0%

Bold means ‘statistically significant p-value’

Back to article page

ISSN: 1752-1505

Contact us

Submission enquiries: journalsubmissions@springernature.com